Phase III FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis

Authors: L. Richeldi, A. Azuma, V. Cottin, M. Kreuter, T.M. Maher, F.J. Martinez, J.M. Oldham, C. Valenzuela, E. Clerisme-Beaty, M. Gordat, D. Wachtlin, Y. Liu, C. Schlecker, S. Stowasser, D.F. Zoz, M.S. Wijsenbeek

Published: 2025-07-01

DOI: 10.1164/ajrccm.2025.211.abstracts.a7993

Source: Full article


Abstract

No abstract found.